Mitra Bio

Non-invasive skin testing to validate precision dermatological therapeutics.

Founded 2021

Founders Shakiba Kaveh, CEO Cristiana Banila, CTO

Healthcare

View Website

Mitra Bio has created a non-invasive skin diagnostics platform to power the development of age rejuvenating compounds. With a combination of clinical trials, non-invasive skin sampling, next-generation sequencing and state-of-the-art data science, Mitra Bio guides the design of novel skincare compounds that work directly on the human skin.

As skin ages, there are characteristic changes in DNA methylation patterns. These changes are influenced by factors like UV exposure, oxidative stress, and inflammation. By analyzing DNA methylation patterns in specific genes related to skin health, one can gain insights into the biological age of the skin and its overall quality. This information can provide valuable data about skin aging, potential damage due to environmental factors, and even predict the efficacy of skincare interventions.

Mitra Bio has invented an at-home test that detects the skin’s biological age, inflammation, and sun damage. Their skin diagnostics platform turns epigenetic biomarkers and data into actionable insights for intervention efficacy, dosage and rejuvenation. Mitra Bio is working closely with leading skincare companies to help them optimize the clinical success of therapeutics.

Founders

Shakiba
Kaveh

CEO

Shakiba holds a PhD from the University of Cambridge in Materials Science, and a First Class Master’s degree from Imperial college London. Before founding Mitra Bio, Shakiba started her career in consulting.

Cristiana
Banila

CTO

As a molecular biologist, Cristiana contributed to development of an epigenetic test for cervical cancer screening which is currently in trial by the NHS. She graduated from Oxford University and Princeton in Biochemistry and Virology.